-
公开(公告)号:US06498187B1
公开(公告)日:2002-12-24
申请号:US10049962
申请日:2002-02-19
Applicant: Siegfried B. Christensen, IV , Robert A. Daines , Jack D. Leber , Israil Pendrak , Joseph Weinstock
Inventor: Siegfried B. Christensen, IV , Robert A. Daines , Jack D. Leber , Israil Pendrak , Joseph Weinstock
IPC: A61K3136
CPC classification number: C07C57/42 , C07D317/62
Abstract: This invention relates to the use of compounds as inhibitors of the fatty acid synthase FabH.
Abstract translation: 本发明涉及化合物作为脂肪酸合酶FabH的抑制剂的用途
-
2.
公开(公告)号:US06486192B1
公开(公告)日:2002-11-26
申请号:US09980164
申请日:2001-11-28
Applicant: Robert A. Daines , Pamela A. Chambers
Inventor: Robert A. Daines , Pamela A. Chambers
IPC: A61K3140
CPC classification number: A61K31/404
Abstract: This invention relates to the use of certain indole compounds, which are active as inhibitors of the fatty acid synthase FabH, for the treatment of bacterial infections.
Abstract translation: 本发明涉及作为脂肪酸合成酶FabH的抑制剂具有活性的某些吲哚化合物用于治疗细菌感染的用途。
-
3.
公开(公告)号:US06469046B1
公开(公告)日:2002-10-22
申请号:US09980304
申请日:2001-11-28
Applicant: Robert A. Daines , Kelvin C. Sham
Inventor: Robert A. Daines , Kelvin C. Sham
IPC: A61K3140
CPC classification number: A61K31/404 , Y02A50/473
Abstract: This invention relates to the use of compounds as inhibitors of the fatty acid synthase FabH useful in treating bacterial infections.
Abstract translation: 本发明涉及化合物作为可用于治疗细菌感染的脂肪酸合酶FabH的抑制剂的用途。
-
4.Indolecarboxamides, pharmaceutical compositions and methods of inhibiting calpain 失效
Title translation: 吲哚酰胺,药物组合物和抑制钙蛋白酶的方法公开(公告)号:US06214856B1
公开(公告)日:2001-04-10
申请号:US09380317
申请日:1999-08-30
Applicant: Robert A Daines , Kelvin Kin-Cheong Sham
Inventor: Robert A Daines , Kelvin Kin-Cheong Sham
IPC: A01N4338
CPC classification number: C07D209/42
Abstract: Pharmaceutical compositions and methods of inhibiting calpain using novel indolecarboxamides are disclosed.
Abstract translation: 公开了使用新型吲哚甲酰胺抑制钙蛋白酶的药物组合物和方法。
-
5.
公开(公告)号:US5700943A
公开(公告)日:1997-12-23
申请号:US356353
申请日:1994-12-20
Applicant: Robert A. Daines
Inventor: Robert A. Daines
IPC: C07D213/65 , C07D213/30 , C07D213/32 , C07D213/55
CPC classification number: C07D213/65
Abstract: This invention relates to a process of making a compound of formula I ##STR1## where R.sub.1 contains an .alpha.,.beta.-unsaturated carbonyl group & R.sub.n is hydrogen or nonhydrogen radicals which do not have a functional group which interferes with the coupling reaction, which process comprises coupling a thiolphenol or phenylalkylmercaptan with a chloromethylpyridine in the presence of DBU under an inert atmosphere. These compounds are leukotriene antagonists and as such can be used in treating various diseases associated with leukotrienes.
Abstract translation: PCT No.PCT / US93 / 06177 Sec。 371日期1994年12月20日第 102(e)日期1994年12月20日PCT提交1993年6月30日PCT公布。 公开号WO94 / 00433 日本1994年1月6日本发明涉及制备式I化合物(I)的方法,其中R1含有α,β-不饱和羰基,Rn为不具有官能团的氢或非氢基团, 干扰偶联反应,该方法包括在惰性气氛下,在DBU存在下将巯基酚或苯基烷基硫醇与氯甲基吡啶偶联。 这些化合物是白三烯拮抗剂,因此可以用于治疗与白细胞三烯相关的各种疾病。
-
6.Pyridine compounds for treating leukotriene-related diseases 失效
Title translation: 用于治疗白三烯相关疾病的吡啶化合物公开(公告)号:US5633258A
公开(公告)日:1997-05-27
申请号:US439537
申请日:1995-05-11
Applicant: Pamela A. Chambers , Robert A. Daines , Dalia R. Jakas , William D. Kingsbury , Israil Pendrak
Inventor: Pamela A. Chambers , Robert A. Daines , Dalia R. Jakas , William D. Kingsbury , Israil Pendrak
IPC: C07D213/28 , C07D213/36 , C07D213/65 , C07F9/58 , A61K31/44 , C07D401/12 , C07D213/64
CPC classification number: C07D213/65 , C07D213/28 , C07D213/36 , C07F9/582
Abstract: ##STR1## This invention relates to compounds of formula (I) which are useful as leukotriene antagonists.
Abstract translation: (I)本发明涉及可用作白三烯拮抗剂的式(I)化合物。
-
7.Diphenyl-2-propenoates for treating diseases associated with leukotriene B4 失效
Title translation: 用于治疗与白三烯B4相关疾病的二苯基-2-丙烯酸酯公开(公告)号:US5569677A
公开(公告)日:1996-10-29
申请号:US464174
申请日:1995-06-05
Applicant: Robert A. Daines
Inventor: Robert A. Daines
IPC: C07C317/46 , C07C323/56 , C07D213/66 , A61K31/19
CPC classification number: C07D213/66 , C07C317/46 , C07C323/56
Abstract: This invention relates to a compound of formula I ##STR1## where the several groups are defined herein. These compounds are leukotriene antagonists and as such can be used in treating various diseases associated with leukotrienes.
Abstract translation: 本发明涉及式I化合物,其中数个基团在本文中定义。 这些化合物是白三烯拮抗剂,因此可以用于治疗与白细胞三烯相关的各种疾病。
-
8.Novel Polymorphs of Rebaudioside C and Methods for Making and Using the Same 审中-公开
Title translation: 雷鲍迪苷C的新型多态性及其制备与使用方法公开(公告)号:US20120230922A1
公开(公告)日:2012-09-13
申请号:US13497619
申请日:2010-09-22
Applicant: F. Raymond Salemme , Robert A. Daines
Inventor: F. Raymond Salemme , Robert A. Daines
IPC: A23L1/236 , A23L2/60 , C07H15/24 , A61Q11/00 , A61K47/26 , A61K8/60 , A61P3/02 , A23L1/30 , C07H1/08
CPC classification number: A61K8/60 , A23L27/36 , A23V2002/00 , A61K8/602 , A61K47/26 , A61K2800/10 , A61Q11/00 , A61Q19/00 , C07H15/24 , A23V2250/258
Abstract: Embodiments of this invention encompass a method for producing and purifying rebaudioside C. In particular, this invention relates to a method for purifying rebaudioside C compositions to obtain a substantially pure rebaudioside C product using one or more crystallization steps. Resulting polymorphic forms of rebaudioside C, substantially pure rebaudioside C compositions and their uses are disclosed.
Abstract translation: 本发明的实施方案包括用于生产和纯化新蛇菊苷C的方法。特别地,本发明涉及一种纯化新蛇菊苷C组合物以使用一种或多种结晶步骤获得基本上纯的莱鲍迪甙C产物的方法。 公开了莱鲍迪苷C,基本上纯的莱鲍迪甙C组合物及其用途的所得多晶型物。
-
公开(公告)号:US20100081650A1
公开(公告)日:2010-04-01
申请号:US12620129
申请日:2009-11-17
Applicant: Jeffrey Michael Axten , Robert A. Daines , David Thomas Davies , Timothy Francis Gallagher , Graham Elgin Jones , William Henry Miller , Neil David Pearson , Israil Pendrak
Inventor: Jeffrey Michael Axten , Robert A. Daines , David Thomas Davies , Timothy Francis Gallagher , Graham Elgin Jones , William Henry Miller , Neil David Pearson , Israil Pendrak
IPC: A61K31/542 , C07D513/02 , C07D498/02 , A61K31/5383 , C07D491/02 , A61K31/436 , A61P31/04
CPC classification number: C07D493/04 , C07D417/12 , C07D513/04
Abstract: Cyclohexane and cyclohexene derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly man.
Abstract translation: 环己烷和环己烯衍生物及其药学上可接受的衍生物可用于治疗哺乳动物,特别是人的细菌感染的方法。
-
公开(公告)号:US07622481B2
公开(公告)日:2009-11-24
申请号:US10518653
申请日:2003-06-25
Applicant: Jeffrey Michael Axten , Robert A Daines , David Thomas Davies , Timothy Francis Gallagher , Graham Elgin Jones , William Henry Miller , Neil David Pearson , Israil Pendrak
Inventor: Jeffrey Michael Axten , Robert A Daines , David Thomas Davies , Timothy Francis Gallagher , Graham Elgin Jones , William Henry Miller , Neil David Pearson , Israil Pendrak
IPC: C07D513/04 , C07D471/04 , A61K31/542 , A61K31/4375
CPC classification number: C07D493/04 , C07D417/12 , C07D513/04
Abstract: Cyclohexane and cyclohexene derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly man.
Abstract translation: 环己烷和环己烯衍生物及其药学上可接受的衍生物可用于治疗哺乳动物,特别是人的细菌感染的方法。
-
-
-
-
-
-
-
-
-